Literature DB >> 6377611

Contrasting effects of thymopentin and splenopentin on the capacity of female mice to reject syngeneic male skin.

E H Goldberg, G Goldstein, D B Harman, E A Boyse.   

Abstract

The TP-5 pentapeptide analog of thymopoietin and the SP-5 pentapeptide analog of splenin, which differ only in substitution of Glu for Asp and represent positions 32-36 of the parent molecules, were compared for effects on the capacity of C3H/HeJ female mice to reject C3H/HeJ male skin (the H-Y rejection response). The actions of these TP-5 and SP-5 analogs of respective thymic and splenic products were already known to differ in other functional systems, neuromuscular and immunological, in vitro and in vivo. The H-Y rejection response of young thymus-intact female mice was heightened by TP-5 and by SP-5. Neither TP-5 nor SP-5 affected the raised H-Y rejection response of splenectomized female mice. Whereas TP-5 lowered the raised H-Y rejection response of thymectomized female mice, as reported elsewhere, SP-5 did not. Thus, not only do these structurally very similar immunoregulators differ in their particular functions, but the overall effect of these functions in vivo depends on the immune status of the recipient.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6377611     DOI: 10.1097/00007890-198407000-00013

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  4 in total

1.  Polarins: a novel group of immunologically active peptides.

Authors:  G Chipens; R Vegners; N Ievina; G Rosenthal
Journal:  Immunol Res       Date:  1986       Impact factor: 2.829

2.  Thymopentin: stability considerations and potency by various routes of administration.

Authors:  T K Audhya; G Goldstein
Journal:  Surv Immunol Res       Date:  1985

Review 3.  Thymopoietin to thymopentin: experimental studies.

Authors:  G Goldstein; T K Audhya
Journal:  Surv Immunol Res       Date:  1985

Review 4.  Thymopentin and splenopentin as immunomodulators. Current status.

Authors:  V K Singh; S Biswas; K B Mathur; W Haq; S K Garg; S S Agarwal
Journal:  Immunol Res       Date:  1998       Impact factor: 2.829

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.